Onvansertib fumarateProduct ingredient for Onvansertib
- Name
- Onvansertib fumarate
- Drug Entry
- Onvansertib
Onvansertib is under investigation in clinical trial NCT03303339 (Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).).
- Accession Number
- DBSALT003265
- Structure
- Synonyms
- 1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy) phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide fumarate salt / NMS-P937 fumarate / NMS-P937 fumarate salt / PCM-075 fumarate
- UNII
- HMP6CI6R6V
- CAS Number
- 1263293-37-3
- External Links
- Not Available
- Predicted Properties
- Not Available